AM21-62: Blood Supply and Role of Patient Blood Management (PBM) in Hospital Transfusion Services during COVID-19 Pandemic: Lessons Learned
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
Due to lockdown and social distancing measures during COVID-19, blood donations dropped significantly at the start of the pandemic. Blood centers (BC) had to continuously adapt to reduction in donations, loss of staff due to COVID-19 exposure and quarantine, and uncertain patterns of demand for blood components. Elective surgeries were temporarily cancelled. Hospital transfusion services had to interact with the BC to continuously maintain the blood supply to meet demand for ongoing critical need. Patient blood management (PBM) is an evidence-based, multidisciplinary approach to optimize the care of patients who might need a transfusion. Following its principles (anemia management, minimization of surgical bleeding and iatrogenic anemia, and guideline-oriented transfusions) was critical during COVID-19 pandemic to ensure adequate blood supply. This session ends with a summary of key lessons learned by blood centers and hospitals during the COVID-19 pandemic.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Explain how blood centers and hospital transfusion services interacted during COVID-19 to ensure an adequate blood supply
- Identify key principles of PBM that were part of the hospital’s COVID-19 response plan
- Summarize key lessons that were learned by blood centers and hospitals during the COVID-19 pandemic
- Describe the challenges that blood centers faced during COVID-19 and how they adapted to them
Moderator(s):
- Mark Friedman, DO, NYU Langone Hospital-Long Island
Speaker(s):
- Alesia Kaplan, Department of Pathology, University of Pittsburgh
- Thomas Watkins, DO, MEDIC Regional Blood Center
Disclosures
- Mark Friedman, DO:
Nothing to Disclose
- Alesia Kaplan:
Nothing to Disclose
- Thomas Watkins, DO:
Consultant: CSL Plasma
AM21-63: Under Cyberattack at the University of Vermont Medical Center: Laboratory Medicine and Anesthesia Share the 25-Day Survival Story
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
The UVM Medical Center was recently the victim of a cyberattack in the midst of a global pandemic. The cyberattack put the entire hospital system into complete downtime procedures for 25 days and left many third party applications disabled for over three months after the attack. It is important to understand the true impact of a cyberattack and to recognize potential strategies for operational and risk-mitigation processes in response to a total and prolonged IT system outage. Based on the experience of a Blood Bank Technical Specialist, a Pathologist, and an Anesthesiologist, participants of this session will learn how the Blood Bank, the general laboratory, the OR, and inpatient units remained nimble, reacted to critical situations not addressed in standard downtime procedures, and implemented creative solutions in order to provide timely and safe patient care. Given the increasing number of cyberattacks targeting healthcare services, now is the time to consider how your hospital can prepare for the very real threat of living through one.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Predict risk-mitigation strategies to ensure hospital staff support and quality patient care during prolonged IT system outage
- Describe the challenges in providing patient care associated with IT system restart
- Define and create recovery plans and downtime recovery remediation summaries to assess recovery status and opportunities for improvement
- Recognize critical operations that require rapid implementation of new processes to support patient care from the patient to the laboratory and back during prolonged IT system outage
Moderator(s):
- Sarah Harm, MD, MSc, Pathologist; Associate Professor, University of Vermont Medical Center
Speaker(s):
- Lyle Gerety, MD, University of Vermont Medical Center
- Lynn Griswold, MT (ASCP), University of Vermont Medical Center
Disclosures
- Sarah Harm, MD, MSc:
Nothing to Disclose
- Lyle Gerety, MD:
Nothing to Disclose
- Lynn Griswold, MT (ASCP):
Nothing to Disclose
AM21-64: Using Quarantechnology to Keep Your Distance: Lessons Learned and Durable Practices in Transforming Workflows during COVID
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
The COVID-19 pandemic brought the need to keep people separated, either to quarantine or decrease viral transmission. In some settings, remote work solutions were already partly utilized and had to be expanded, and in other cases, completely new telehealth solutions were implemented to meet the continuing and growing work demands in transfusion and blood banking. Overall, the global pandemic quickly forced universal adoption of these tools to facilitate social distancing. While some technology solutions improved workflows and efficiency, these implementations also provided their own challenges. The technology tools range from video conferencing to chat tools to remote system access. We review these tools and implementation considerations as well as case studies of remote work in action.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe steps for implementation and security concerns for remote healthcare work
- Review use cases of remote work for different settings
- Discuss continuing use of successful solutions in a post-COVID era
- Identify technologies available for remote work and telehealth applicable to blood center or laboratory function.
Moderator(s):
- Jessica Poisson, MD, Duke University Hospital
Speaker(s):
- Hamilton C. Tsang, MD, Associate Medical Director, Transfusion, University Of Washington
- Mandy O'Leary, MD, MPH, Pathologist, H. Lee Moffitt Cancer Center
Disclosures
- Hamilton Tsang, MD:
Stock Shareholder: Zoom, Microsoft, Amazon, Apple, Google, Facebook
- Jessica Poisson, MD:
Consultant: Secure Transfusion Services
- Mandy O'Leary, MD, MPH:
Nothing to Disclose
AM21-65: Optimizing Electronic Medical Records for the Transfusion Service with Workflows, Clinical Decision Support and Dashboards
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
Transfusions are the most commonly performed procedure in the United States and therefore require significant information technology investment for workflow optimization. This session will discuss easily implemented electronic medical record solutions to enhance transfusion service efficiency and safety. Topics that will be covered include: use of blood orders with clinical decision support in both adult and pediatric patients, tools to improve patient identification during specimen collection and blood administration, electronic integration of massive hemorrhage protocol and emergency release blood ordering and administration, enhancing clinical recognition of patients with red blood cell antibodies, and strategies to reduce collection of unacceptable specimens. Interactive transfusion clinical dashboards to improve blood bank communication with patient care teams will be illustrated.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe how electronic medical record logic can enhance patient safety and lab efficiency
- Demonstrate how interactive clinical dashboards can improve blood bank communication with patient care teams
- Discuss implementation of clinical decision support in electronic blood ordering
Moderator(s):
- Melissa Cushing, MD, Executive Vice Chair, Weill Cornell Medicine Department of Pathology and Laboratory Medicine
Speaker(s):
- Joel N. Kniep, MD, University of Colorado
- Robert DeSimone, MD, Director of Transfusion Medicine, Weill Cornell Medicine
Disclosures
- Joel Kniep, MD:
Nothing to Disclose
- Robert DeSimone, MD:
Nothing to Disclose
- Melissa Cushing, MD:
Nothing to Disclose
AM21-66: Bloody Errors - How Humans Are Hardwired to Make Mistakes and What Steps We Can Do in the Blood Bank to Prevent Them
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
The root cause of many adverse events in healthcare is attributed to “human factors”. Processes can be changed to reduce the possibility of mistakes, but no system is completely human proof. In this session we will investigate perception errors and demonstrate how our brain’s normal functions cause our perception to be blinded to inconsistencies in details. The session will include discussion of cases where errors occurred which could have been avoided and recommendations to improve recognition of inconsistencies.
Types of error to be discussed are those which relate to the confirmation of information, this could be confirming the patient details when taking a sample or administering blood. Especially pertinent is the comparison on auditory and visual information such as asking the patient to state their name or checking with a colleague This can cover the entire pre-transfusion process but is also applicable to other situations such as checking drugs. Delegates were encouraged to share their own experiences of errors and examine how perception errors have contributed to his or her blood banking experiences.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Recognize areas of their own practice where perception errors can occur and assess the risk of errors going undetected.
- Integrate strategies to reduce the likelihood of perception errors into procedures, training and working practice.
- Identify areas to improve processes that require patient or product identification.
- Discuss the relevant neurological functions and social science theory surrounding the causes of perception errors and the experiments which demonstrate these.
Moderator(s):
- Daniela Hermelin, MD, Chief Medical Officer, ImpactLife Medical Affairs
Speaker(s):
- Juliet Smith, RN, Queen Elizabeth Hospital
Disclosures
- Daniela Hermelin, MD:
Nothing to Disclose
- Juliet Smith, RN:
Nothing to Disclose
AM21-68: In Vitro and In Vivo Evidence for the Use of Cold Stored Platelets
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
Standard platelet units are stored at room temperature (20-24°C) for up to 5 to 7 days. This short expiration date limits platelet supply, particularly in rural areas. In addition, platelet function declines and bacterial growth may occur in this storage condition. Alternative strategies to preserve platelets are needed to ensure adequate platelet supply for all bleeding patients. Platelets are currently FDA approved to store cold (1-6°C) for up to 3 days. Laboratory data suggests that cold storage may preserve platelet function longer, up to more than 20 days. Clinical data suggests that cold stored platelets may be effective in controlling bleeding. This session will review the in vitro and in vivo data available on the use of cold stored platelets.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Differentiate the impact of cold and room temperature storage on platelet function.
- Describe the data on clinical use of cold stored platelets.
- Review storage conditions for platelets.
Moderator(s):
- Dr. Nicole D. Zantek, MD, PhD, Department of Laboratory Medicine and Pathology, University of Minnesota
Speaker(s):
- Mortiz Stolla, MD, PhD, Bloodworks Northwest Research Institute
- Dr. Kimberly A. Thomas, PhD, Washington University in St. Louis, Pediatrics Critical Care Dept.
Disclosures
- Nicole Zantek, MD, PhD:
Spouse Stock Shareholder: ENDO International PLC; Spouse Employee: Boston Scientific
- Mortiz Stolla, MD, PhD:
Grant/Research Support: Terumo, Cerus
- Kimberly Thomas, PhD:
Nothing to Disclose
AM21-69: Patient Blood Management in Merging Hospitals - How Do You Keep the Momentum Going?
Oct 18, 2021 2:45pm ‐ Oct 18, 2021 3:45pm
Expiration Date: Dec 31, 2023
Credits: None available.
Due to financial constraints and economies of scale many hospitals are merging. Changes in executive leadership and staff can transform the strategic plan. While a merger is of equals, often their patient blood management (PBM) programs are not. Each may carry its own strengths and weaknesses. It is important that the PBM program continue to play a prominent role in the healthcare system culture post-merger. This session will discuss how two hospital systems, each with its own PBM program and with the assistance of a blood center were able to grow their programs post-merger. As data mining is critical for effective PBM, the session will also discuss the challenges of integrating information using two different laboratory software systems and electronic medical records. Finally, the session will discuss the process of how two different hospitals reconcile commonalities and differences in efforts to harmonize performance and to leverage best practice synergies to improve PBM influence.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe resources and tools needed to harmonize disparate information systems into meaningful metrics.
- Appraise the successes and challenges encountered with the merger of PBM programs through a series of case scenarios.
- Define a process for combining PBM program strengths in the merged health system.
Moderator(s):
- Dr. Deborah Tolich, DNP, RN, Cleveland Clinic
Speaker(s):
- Moises Auron, MD, FAAP, FACP, SFHM, Cleveland Clinic
- Richard Gammon, MD, Medical Director, OneBlood
Disclosures
- Deborah Tolich, DNP, RN:
Nothing to Disclose
- Moises Auron, MD, FAAP, FACP, SFHM:
Nothing to Disclose
- Richard Gammon, MD:
Nothing to Disclose
AM21-70: Physician Communicators: Utilizing Blood Center Medical Directors to Increase Blood Collections
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
As the landscape in our industry changes, it is increasingly more difficult to attract and retain blood donors. However, blood center physicians can have a significant impact on this challenge. In this session, attendees will learn how blood center physicians are finding creative ways to increase blood donations, enhance public relations, and educate the general public about blood donations. These unique physician initiatives add value and increase blood center collections.
Benefits of promoting a physician as the “face” of a blood center include improving donor attitudes by humanizing the donation process, associating donation with patient treatment, and increasing knowledge of blood use.
Speakers will discuss the development of physician communications and simple steps to help physicians, often not used to public speaking, feel comfortable speaking about blood donation. Social media and other communication outlets are leveraged to maximize messaging from the blood center physician.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe multiple creative programs, led by blood center physicians, targeted at increasing blood donations and educating the general public on the need for blood
- Design a cohesive communication plan, including social media and traditional outlets, involving physician messaging to blood donors
- Identify opportunities for blood centers to use physicians as spokespeople to encourage blood donation
Moderator(s):
- Alecia Lipton, MHA, Hoxworth Blood Center
Speaker(s):
- David Oh, MD, Hoxworth Blood Center
- Michelle Johnson, MT(ASCP), MBA, Lifestream
Disclosures
- David Oh, MD:
Nothing to Disclose
- Alecia Lipton, MHA:
Nothing to Disclose
- Michelle Johnson, MT(ASCP), MBA:
Nothing to Disclose
AM21-71: Leadership and the Importance of Emotional Intelligence in a Virtual Work Environment
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
The COVID pandemic has significantly changed the work environment with many people working from home. Some companies are beginning to ask their employees to return to the office, while others will implement a hybrid of in-office and remote environments. This new paradigm can be challenging for leaders as managing is no longer “business as usual”. Leadership traits must adapt to ensure inclusivity and accountability of all employees, especially those who work remotely. Leadership traits include effective communication, motivation, collaboration and trust. High emotional intelligence is most important when engaging virtually with others. Join us as we explore the traits of leadership and emotional intelligence in the virtual work environment.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe the characteristics of emotional intelligence
- Recognize the characteristics of emotional intelligence in a virtual leadership setting
- Describe leadership traits necessary for managing in a virtual environment
Speaker(s):
- Dr. Lynne Uhl, Beth Israel Deaconess Medical Center
- Jean Stanley, MBA, MT(ASCP)SBB, CMQ/OE(ASQ), Health Care Consultant
Disclosures
- Lynne Uhl:
Consultant: UpToDate, Grifols, Inc., Abbott; Grant/Research Support, DSMB: NHLBI
- Jean Stanley, MBA, MT(ASCP)SBB, CMQ/OE(ASQ):
Contractor: Roche Molecular Solutions, Inc.; Speaker's Bureau: BCSolutions, LLC; Consultant: Quality Focus
AM21-72: FDA Office of Regulatory Affairs Oversight during a Public Health Emergency
Oct 19, 2021 8:00pm ‐ Oct 19, 2021 9:00pm
Expiration Date: Dec 31, 2023
Credits: None available.
This session will be presented by FDA’s Office of Regulatory Affairs, Office of Biological Product Operations investigations and operations staff. Discussion will include FDA’s current regulatory oversight to include mission critical work, remote regulatory assessments under Section 704(a)(4) and prioritized domestic inspections. Best practices and recommendations will be presented on what to expect after receipt of an FDA Inspection Records Request, as well as how to prepare for and what to expect before, during and after onsite mission critical inspections to promote inspectional readiness.
To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
- Describe FDA’s OBPO organizational structure, and best practices for communicating with OBPO.
- Discuss a high-level overview of an FDA inspection, to include how to prepare for inspections and what to expect before, during and after the inspection; to include any oversight of convalescent plasma.
- Describe FDA’s Office of Regulatory Affairs, Office of Biological Products Operations (OBPO) current inspectional activities, to include remote regulatory assessments, pre-announcements and safety measures, during the current public health emergency.
Moderator(s):
- Tricia Martinez, Director, Investigations Branch, FDA Office of Regulatory Affairs, Office of Biological Products Operations
Speaker(s):
- Catherine Quinlan, FDA Office of Regulatory Affairs
- Tania Hall, FDA Office of Regulatory Affairs
Disclosures
- Catherine Quinlan:
Nothing to Disclose
- Tania Hall:
Nothing to Disclose
- Tricia Martinez:
Nothing to Disclose